NPPES file of Aug 9, 2026

Douglas Weston Sborov, M.D.

Hematology & Oncology Physician · Salt Lake City, UT

Douglas Weston Sborov, M.D. is a hematology & oncology physician with a practice address in Salt Lake City, Utah, and NPI 1942444609, issued on Apr 26, 2009. Check the license (Utah 7769969-8905, as entered in NPPES) on the Utah Medical Licensing Board; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1942444609
Name
Douglas Weston Sborov
Credential
M.D.
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License numbers
7769969-8905 UT
35122859 OH
Self-reported in NPPES; status is on the state search
Practice location
1950 Circle OF Hope Dr, Salt Lake City, UT 84112
Phone
(801) 213-3800
Enumerated
Apr 26, 2009
Record last updated
Nov 17, 2021 (not updated in 5 years: call before relying on the address or phone)
Medicare enrollment
Enrolled (PECOS I20160830001141); accepts Medicare assignment
Telehealth
Offers telehealth (CMS)
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1950 Circle OF Hope Dr

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Saeed Abbaszadeh, PA-CPhysician Assistant1720003544
  2. Katherine Arnone, PAPhysician Assistant1760137400
  3. Philip Bernard, M.D.Anatomic Pathology & Clinical Pathology Physician1851778872
  4. Kate Blake, NPNurse Practitioner1073391025
  5. Grace BlissellNurse Practitioner1417428582
  6. Brittney Brito, PHARMDOncology Pharmacist1366320160

Verify Douglas Weston Sborov in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersUtah Medical Licensing Board
    Search for license 7769969-8905
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Utah license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

59% more Medicare Part D claims than the average hematology & oncology physician in 2024

1,397 Medicare Part D claims for 140 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 40% of claims.

  1. Douglas Sborov1,397
  2. Specialty average877

Most prescribed

  1. Acyclovir338 claims
  2. Revlimid260 claims
  3. Pomalyst96 claims
  4. Eliquis94 claims
  5. Dexamethasone75 claims
  6. Omeprazole70 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 92.1 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score85.6
  2. Costnot scored (reweighted)
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $173,014.17

22 payments; by number, the most common kind was consulting fee; the largest payer was GlaxoSmithKline, LLC. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Douglas Sborov$173,014
  2. Specialty average$7,481

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. University OF Utah Adult ServicesSalt Lake City, UT

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Douglas Weston Sborov among 99 hematology & oncology physician records in Utah

Douglas Weston Sborov, M.D. is one of 99 hematology & oncology physician records with a practice address in Utah. 80% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2009, is newer than 46% of them.

  • NPI issued2009 · 46% of these records are older, 48% newer
  • In a Medicare fileYes · 80% of these records are
  • In the CMS Doctors and Clinicians fileYes · 66% of these records are
  • Graduated2009 · median 2009 among the 65 with a school on file
  • Record last updated2021 · 52% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Utah practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Hematology & Oncology Physician providers in Utah

There are 99 hematology & oncology physician records in Utah.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. Neeraj Agarwal, MDSalt Lake City, UT 841121417078221
  2. Daniel Couriel, M.D.Salt Lake City, UT 841121275627309
  3. Launce Gouw, M.D., PH.D.Salt Lake City, UT 841121689788325
  4. Kelly Konopa, MDSalt Lake City, UT 841121033272489
  5. Hwee Yong Lim, MB BCH BAOSalt Lake City, UT 841121780870881
  6. Brian McClune, DOSalt Lake City, UT 841121649296880
  7. Birgitta Mitchell, MDSalt Lake City, UT 841121982887741
  8. Shiven Patel, MD, MBA, FACPSalt Lake City, UT 841121023276490

Common questions

What is Douglas Weston Sborov, M.D.'s NPI number?

Douglas Weston Sborov, M.D.'s National Provider Identifier (NPI) is 1942444609, issued on Apr 26, 2009. An NPI identifies a provider in billing; it is not a license.

Where is Douglas Weston Sborov, M.D. located?

The NPPES record lists a practice address at 1950 Circle OF Hope Dr, Salt Lake City, UT, 84112. Phone: (801) 213-3800. Providers update this record themselves, so call before visiting.

How can I verify Douglas Weston Sborov, M.D.'s license?

NPPES lists Utah license number 7769969-8905, as entered by the provider. Search the Utah Medical Licensing Board at https://secure.utah.gov/llv/search/index.html. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Douglas Weston Sborov, M.D. prescribe under Medicare Part D?

In 2024, Douglas Weston Sborov, M.D. had 1,397 Medicare Part D claims for 140 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

What is Douglas Weston Sborov, M.D.'s MIPS final score?

The 2023 MIPS final score is 92.1 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.